Regarding the clinical significance of PRMT4, 5, and 7, as well as arginine methylation on hnRNPA1, they were highly expressed in several types of cancers, such as breast, colorectal, and prostate cancer, which is associated with aberrant alternative splicing events. Here, HNRNPA1 is linked to prostate carcinoma.